The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections
Crossref DOI link: https://doi.org/10.1007/s40121-017-0148-z
Published Online: 2017-03-06
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Flynt, Lauren K.
Kenney, Rachel M.
Zervos, Marcus J.
Davis, Susan L.